IMMUCOR INC
S-3/A, 1999-05-28
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: VANGUARD SPECIALIZED PORTFOLIOS INC, 485BPOS, 1999-05-28
Next: BRAUVIN REAL ESTATE FUND LP 4, PRE 14A, 1999-05-28




                              [IMMUCOR LETTERHEAD]


Via Facsimile (202) 942-9533 and EDGAR

Mr. Jeffrey Riedler
Securities and Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W., Mail Stop 3-9
Washington, D.C.  20549

Dear Mr. Riedler:

         Immucor hereby amends its Registration Statement on Form S-3 filed with
the Commission on May 20, 1999, by including the following language:

         The Registrant hereby amends this  Registration  Statement on such date
         or dates as may be  necessary  to delay its  effective  date  until the
         Registrant  shall file a further  amendment which  specifically  states
         that this  Registration  Statement shall thereafter become effective in
         accordance with Section 8(a) of the Securities Act of 1933 or until the
         Registration  Statement  shall  become  effective  on such  date as the
         commission acting pursuant to said Section 8(a) may determine.

         If you have any  questions,  please do not  hesitate  to  contact  Andy
Howell at (404) 817-6198.

                                                     Sincerely,

                                                     /s/ Steven C. Ramsey

                                                     Steven C. Ramsey

SCR/ah



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission